These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17408938)

  • 61. In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
    Fischer H; Atzpodien EA; Csato M; Doessegger L; Lenz B; Schmitt G; Singer T
    J Med Chem; 2012 Jan; 55(1):126-39. PubMed ID: 22122484
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of fluorescence imaging-based assay for screening cardioprotective compounds from medicinal plants.
    Wang Y; Zhao X; Gao X; Nie X; Yang Y; Fan X
    Anal Chim Acta; 2011 Sep; 702(1):87-94. PubMed ID: 21819864
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay.
    Donato MT; Tolosa L; Jiménez N; Castell JV; Gómez-Lechón MJ
    J Biomol Screen; 2012 Mar; 17(3):394-400. PubMed ID: 22116976
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk.
    Okamoto H; Hamaguchi R; Kuroda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():33-40. PubMed ID: 28285021
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Newborn response to cationic amphiphilic drugs.
    Kacew S; Reasor MJ
    Fed Proc; 1985 Apr; 44(7):2323-7. PubMed ID: 2579857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fluorescent benzofurazan-cholic acid conjugates for in vitro assessment of bile acid uptake and its modulation by drugs.
    Rohacova J; Marín ML; Martinez-Romero A; Diaz L; O'Connor JE; Gomez-Lechon MJ; Donato MT; Castell JV; Miranda MA
    ChemMedChem; 2009 Mar; 4(3):466-72. PubMed ID: 19173214
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Phospholipidosis induced by chlorimipramine in rat lung].
    Gremigni D; Vannelli G; Sgaragli GP; Mengazzini I
    Boll Soc Ital Biol Sper; 1980 May; 56(10):1078-82. PubMed ID: 7448010
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Drug-induced lipidosis: formation of myeloid bodies (author's transl)].
    Yamamoto A; Seki K; Kitani T; Matsuzawa Y; Adachi S
    Tanpakushitsu Kakusan Koso; 1974 Apr; 19(4):275-93. PubMed ID: 4369542
    [No Abstract]   [Full Text] [Related]  

  • 70. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864.
    Rudmann DG; McNerney ME; VanderEide SL; Schemmer JK; Eversole RR; Vonderfecht SL
    Toxicol Pathol; 2004; 32(3):326-32. PubMed ID: 15204974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis.
    Tomida T; Ishimura M; Iwaki M
    J Toxicol Sci; 2017; 42(5):641-650. PubMed ID: 28904299
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tandem screening of toxic compounds on GFP-labeled bacteria and cancer cells in microtiter plates.
    Montoya J; Varela-Ramirez A; Shanmugasundram M; Martinez LE; Primm TP; Aguilera RJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):367-72. PubMed ID: 16081045
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach.
    Gerets HH; Hanon E; Cornet M; Dhalluin S; Depelchin O; Canning M; Atienzar FA
    Toxicol In Vitro; 2009 Mar; 23(2):319-32. PubMed ID: 19110050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multidimensional drug profiling by automated microscopy.
    Perlman ZE; Slack MD; Feng Y; Mitchison TJ; Wu LF; Altschuler SJ
    Science; 2004 Nov; 306(5699):1194-8. PubMed ID: 15539606
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats.
    Reasor MJ; McCloud CM; Beard TL; Ebert DC; Kacew S; Gardner MF; Aldern KA; Hostetler KY
    Toxicology; 1996 Jan; 106(1-3):139-47. PubMed ID: 8571385
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Imaging Mass Microscopy of Kidneys from Azithromycin-Treated Rats with Phospholipidosis.
    Sakurai T; Kamio K; Sasaki K; Nishimoto T; Yamaguchi JI; Sasaki M; Tsutsumi S
    Am J Pathol; 2018 Sep; 188(9):1993-2003. PubMed ID: 29981744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pathological Features of Corneal Phospholipidosis in Juvenile White Rabbits Induced by Ocular Instillation of Chloroquine or Amiodarone.
    Yamagiwa Y; Takei Y; Koizumi H; Nemoto S; Kurata M; Satoh H
    Toxicol Pathol; 2019 Jan; 47(1):26-34. PubMed ID: 30373479
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biochemical and functional analysis of rat bronchoalveolar macrophages containing chemically induced phospholipid inclusions.
    Waites CR; Bugelski PJ; Badger AM
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):316-21. PubMed ID: 7871542
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug-induced phospholipidosis caused by combinations of common drugs in vitro.
    Glock M; Muehlbacher M; Hurtig H; Tripal P; Kornhuber J
    Toxicol In Vitro; 2016 Sep; 35():139-48. PubMed ID: 27221059
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro validation of drug-induced phospholipidosis.
    Park S; Choi YJ; Lee BH
    J Toxicol Sci; 2012; 37(2):261-7. PubMed ID: 22467016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.